KLOW is a multi-peptide research blend containing 50MG GHK-Cu, 10MG TB-500, 10MG BPC-157, and 10MG KPV, studied in models involving tissue-response signaling, skin biology, inflammatory pathways, connective tissue research, epithelial barrier biology, and cellular remodeling.